241 related articles for article (PubMed ID: 310884)
21. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
Cruz M; Mejia G; Lavalle C; Cortes JJ; Reyes PA
Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675
[TBL] [Abstract][Full Text] [Related]
22. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
Benhamou CL; Amor B; Menkes CJ; Delbarre F
Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
[TBL] [Abstract][Full Text] [Related]
23. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
[TBL] [Abstract][Full Text] [Related]
24. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
Jonsson J
Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
[TBL] [Abstract][Full Text] [Related]
25. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
26. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
27. [Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)].
Nasonova VA; Poverennyĭ AM; Nasonov EL; Lekakh IV; Tachmuradova MD
Ter Arkh; 1985; 57(5):94-8. PubMed ID: 3161200
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
[TBL] [Abstract][Full Text] [Related]
29. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
30. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
31. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
Miyachi K; Tan EM
Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
[TBL] [Abstract][Full Text] [Related]
32. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
33. [HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
Balthazar PA; Gabriel Júnior A; de Oliveira DP; de Oliveira MA; Rosales T; Iglesias SS; Assad RL; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):249-53. PubMed ID: 3879739
[No Abstract] [Full Text] [Related]
34. Clinical significance of antibodies to ribonucleoprotein.
Cohen ML; Dawkins B; Dawkins RL; Owen ET
Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
[TBL] [Abstract][Full Text] [Related]
35. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
Grennan DM; Bunn C; Hughes GR; Buchanan WW; Dick WC
Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
[TBL] [Abstract][Full Text] [Related]
36. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
37. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
38. Mixed connective tissue disease syndrome.
Gilliam JN; Prystowsky SD
Arch Dermatol; 1977 May; 113(5):583-7. PubMed ID: 67824
[TBL] [Abstract][Full Text] [Related]
39. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
40. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
Kallenberg CG; Wouda AA; The TH
Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
